Jiangsu Hengrui Pharmaceuticals Co., Ltd. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-22KLRAKailera Therapeutics, Inc.J — Other acquisition / disposition2.03M—
2026-04-22KLRAKailera Therapeutics, Inc.J — Other acquisition / disposition9.48M—

Companies — Last 90 Days

Frequently Asked Questions

Who is Jiangsu Hengrui Pharmaceuticals Co., Ltd.?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a corporate insider — currently tracked as 10% Owner of Kailera Therapeutics, Inc. (KLRA). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Jiangsu Hengrui Pharmaceuticals Co., Ltd. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Jiangsu Hengrui Pharmaceuticals Co., Ltd. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.